China Medical System Holdings Limited

SHSC:867 Stock Report

Market Cap: HK$18.2b

China Medical System Holdings Past Earnings Performance

Past criteria checks 2/6

China Medical System Holdings has been growing earnings at an average annual rate of 4%, while the Pharmaceuticals industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 7.4% per year. China Medical System Holdings's return on equity is 8.6%, and it has net margins of 19.8%.

Key information

4.0%

Earnings growth rate

4.3%

EPS growth rate

Pharmaceuticals Industry Growth5.6%
Revenue growth rate7.4%
Return on equity8.6%
Net Margin19.8%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How China Medical System Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SHSC:867 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 247,0141,3903,272225
31 Mar 247,5141,8963,220210
31 Dec 238,0132,4013,168195
30 Sep 238,6632,8913,313170
30 Jun 239,3133,3813,457146
31 Mar 239,2323,3203,408136
31 Dec 229,1503,2593,358125
30 Sep 229,0463,2243,347129
30 Jun 228,9423,1893,336133
31 Mar 228,6403,1033,159124
31 Dec 218,3373,0172,981115
30 Sep 218,0092,9482,78294
30 Jun 217,6812,8782,58373
31 Mar 217,3132,7042,44470
31 Dec 206,9462,5302,30467
30 Sep 206,5822,3002,19863
30 Jun 206,2172,0702,09260
31 Mar 206,1452,0152,11953
31 Dec 196,0741,9612,14545
30 Sep 195,9082,0112,10330
30 Jun 195,7432,0622,06015
31 Mar 195,5881,9561,9888
31 Dec 185,4331,8501,9160
30 Sep 185,3751,8391,8290
30 Jun 185,3171,8271,7430
31 Mar 185,3331,7511,6740
31 Dec 175,3491,6751,6040
30 Sep 175,3791,6011,5660
30 Jun 175,4101,5271,5290
31 Mar 175,1551,4521,4620
31 Dec 164,9011,3761,3950
30 Sep 164,4771,2651,2590
30 Jun 164,0541,1551,1230
31 Mar 163,8041,0751,0650
31 Dec 153,5539961,0070
30 Sep 153,4041,0629570
30 Jun 153,2551,1289080
31 Mar 153,1001,0878450
31 Dec 142,9451,0467830
30 Sep 142,7608907290
30 Jun 142,5757346760
31 Mar 142,4126856440
31 Dec 132,2496366130

Quality Earnings: 867 has high quality earnings.

Growing Profit Margin: 867's current net profit margins (19.8%) are lower than last year (36.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 867's earnings have grown by 4% per year over the past 5 years.

Accelerating Growth: 867's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 867 had negative earnings growth (-58.9%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (9.4%).

Return on Equity

High ROE: 867's Return on Equity (8.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 05:17
End of Day Share Price 2024/12/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China Medical System Holdings Limited is covered by 34 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jessica LiBofA Global Research
Lok Kwan ChiuCCB International Securities Limited
Harry HeChina Galaxy International Securities (Hong Kong)